保健品
Search documents
“专业指导”不该成销售套路
Jing Ji Ri Bao· 2025-08-12 23:19
理性与科学是去伪存真的利器。要鼓励医疗卫生机构和医务人员开展健康教育,让专业人士多做科普工 作,帮助居民提升健康素养。加大权威健康指南的宣传力度,定期开展公益讲座,帮助居民养成健康生 活方式。当科学知识便捷可及,健康生活理念深入人心,那些以提供"营养指导"为幌子的营销套路,自 然就失去了生存土壤。 (文章来源:经济日报) "专业指导"不该成为销售套路。要完善营养指导资质认证体系。可借鉴推广深圳"医码通"经验——扫码 查看营养师的执业资质和投诉记录,帮助公众辨别真伪。还要压实平台审查责任,对"营养师"账号实 行"双验证"。一方面,清理"营养顾问""健康讲师"等模糊头衔,验证营养师资质;另一方面,多渠道验 证"营养指导"内容的科学性和真实性,屏蔽虚假宣传。 产品包装上写着食用量每日1片至2片的维生素C,"营养师"却建议一天吃30片到40片。近期,一则关于 保健品"营养指导"的报道,揭露出该行业的乱象。近年来,打着"营养师"旗号推荐保健品的现象屡见不 鲜,一些所谓"专业指导",实际上是商家卖货的套路。 随着保健品市场规模持续扩大,"营养指导"专业服务与营销的边界日益模糊。一些商家通过伪造案例、 夸大产品功效等手段诱 ...
中新自贸协定升级红利持续释放,为两国经贸往来注入不竭动能
Di Yi Cai Jing· 2025-08-12 13:01
Core Viewpoint - The article emphasizes the need for China and New Zealand to accelerate bilateral economic and trade cooperation, particularly in advanced fields such as food science, low-carbon technology, agricultural economy, digital trade, and biopharmaceuticals [1][7]. Bilateral Trade Overview - In 2024, the bilateral trade volume between China and New Zealand reached $20.15 billion, with China exporting $7.74 billion and importing $12.42 billion [2]. - From January to June 2025, the cumulative trade volume was $10.85 billion, showing a year-on-year growth of 6.3%, with exports from China decreasing by 1.6% and imports increasing by 10.8% [2]. Economic Cooperation Landscape - The economic relationship has evolved beyond traditional goods trade to include diversified cooperation in areas such as deep processing of agricultural products, technological innovation, green finance, and the digital economy [3]. - The implementation of the China-New Zealand Free Trade Agreement (FTA) has led to a significant increase in bilateral trade, with nearly NZD 30 billion growth since its inception [3]. Trade Surplus and Policy Environment - New Zealand has maintained a trade surplus with China for eight consecutive years from 2017 to 2024, aided by the favorable policy environment created by the FTA [4]. - New Zealand's unique resources and technological advantages in food science, environmental protection, and agricultural economy have driven trade growth, particularly in dairy, meat, timber, fruits, and organic products [4]. Strategic Initiatives and Future Prospects - New Zealand has established a strategic advantage in bilateral cooperation with China through various pioneering initiatives, including being the first developed country to sign a comprehensive FTA with China [5]. - The upgraded FTA has significant implications for China's new development pattern and high-quality opening-up, facilitating cooperation in key areas like dairy and forestry [6]. Continued Cooperation and Future Directions - The ongoing benefits from the upgraded FTA are expected to inject continuous momentum into bilateral trade, with a focus on expanding market access and reducing institutional transaction costs [7]. - Future cooperation should prioritize advanced fields such as food science, low-carbon technology, agricultural economy, digital trade, and biopharmaceuticals, establishing a new model for South-South cooperation [7].
40岁以后最高级的炫富,你中了几条?
洞见· 2025-08-12 12:35
Group 1 - The article emphasizes that true wealth lies in health and relationships rather than material possessions, especially after the age of 40 [2][5]. - It lists key aspects of a fulfilling life, including quality sleep, a caring partner, grateful children, close friends, and good health [2][5]. - The importance of maintaining family health is highlighted, with a focus on personal health as a foundation for supporting family responsibilities [2]. Group 2 - Australian health products are noted for their high quality due to superior raw materials and strict regulatory standards [4][6][8]. - The article mentions that Australia has abundant natural resources, such as Antarctic algae and deep-sea fish oil, which are free from pollution [6]. - The rigorous safety certification process in Australia ensures that health products are reliable and free from harmful substances [8]. Group 3 - Specific Australian health products are recommended, including A2 organic high-calcium milk powder, which is popular for its nutritional benefits [17][22]. - The article discusses the benefits of Queensland quinoa chia oat flakes, highlighting their high protein and fiber content [27][31]. - The article also features the benefits of the Australian brand "Mighty Greens," which is rich in dietary fiber and aids in detoxification [34][37]. Group 4 - The article promotes a variety of Australian products, such as Manuka honey, which is beneficial for digestive health [51][54]. - It mentions the Red Seal toothpaste, known for its natural ingredients that promote oral health [57][59]. - The upcoming live stream event will showcase these products and offer exclusive deals, encouraging readers to participate [63][69].
中国超1亿便秘人群,为何市场无爆款?
Zhong Guo Chan Ye Jing Ji Xin Xi Wang· 2025-08-12 08:45
Core Insights - The article highlights the significant issue of constipation affecting over 100 million people in China, emphasizing the inadequacy of existing solutions in the market that fail to address the root causes of the problem [1] Industry Analysis - The current market for constipation relief products lacks a "breakthrough" product due to a focus on short-term solutions rather than long-term health [1] - Many existing products rely on harsh laxatives that can lead to dependency and further complications, creating a vicious cycle for users [1] - Probiotics, while a step in the right direction, often fall short due to slow effects and challenges in effective colonization, leading to user frustration [1] - Most products only aim for immediate relief without addressing the underlying issues of energy and moisture deficiency in the intestines, resulting in a high likelihood of recurrence [1] Company Overview - Shenzhen San Ye Biological has developed Lin Da Tong soft capsules, which integrate 22 years of research in the field of food and medicine, aiming to redefine the approach to constipation relief [3][9] - The product utilizes a unique "clear first, then supplement" methodology, combining effective ingredients like high-activity aloe vera and American ginseng to provide both immediate relief and long-term health benefits [4][9] - The aloe vera extract is designed to gently stimulate intestinal movement and soften stool, while the American ginseng nourishes the body and restores intestinal function [9] Product Value Proposition - Lin Da Tong soft capsules address user pain points by offering a dual solution that ensures both quick relief and prevention of recurrence, leading to a high repurchase rate of over 92% for related products [10] - The company is recognized as a national high-tech enterprise with a strong brand reputation, supported by over 20,000 successful agents, ensuring a reliable market presence and product safety [10][12] - The market for constipation relief is vast, with a potential worth billions, and Lin Da Tong is positioned as a key player ready to meet the unmet needs of this significant consumer base [12]
汤臣倍健:季度收入利润波动受市场需求和销售政策等因素影响
Sou Hu Cai Jing· 2025-08-12 08:38
Core Viewpoint - The company acknowledges significant fluctuations in quarterly sales and profits, attributing these variations to market demand, sales policies, promotional activities, and expenditure timing [1] Group 1 - The company received an inquiry regarding the substantial differences in sales and profits from the first quarter to the fourth quarter [1] - The company indicated that the majority of sales occur in the first quarter, raising questions about the sales challenges in other quarters [1] - The company expressed gratitude for the investor's interest and provided insights into the factors influencing quarterly revenue and profit fluctuations [1]
研报掘金丨华鑫证券:维持汤臣倍健“买入”评级,预计全年营收降幅进一步收窄
Ge Long Hui A P P· 2025-08-12 07:34
Core Viewpoint - The report from Huaxin Securities indicates that Tongchen Beijian has narrowed its revenue decline in Q2, optimizing resource allocation dynamically, leading to improved profitability [1] Revenue Performance - In H1 2025, the revenue for the main brand, Jianliduo, Lifespace domestic products, and overseas LSG was down by 28%, 30%, 34%, and up by 13% respectively, amounting to 1.888 billion, 0.411 billion, 0.138 billion, and 0.534 billion yuan [1] Sales Channels - Revenue from offline and online channels in H1 2025 decreased by 32% and 14% respectively, reaching 1.798 billion and 1.684 billion yuan [1] - The online channel is currently undergoing strategic adjustments, including the establishment of a self-broadcasting team to reduce expenses [1] - The offline channel focuses on cost reduction and efficiency improvement, optimizing the distribution system, with a net reduction of 147 distributors to 640 by the end of H1 2025 [1] Future Strategies - The company plans to stabilize its business through multiple strategies, including enriching SKU, lowering price points, and a distributor awakening plan [1] - The internal adjustments are ongoing, with significant improvement in profitability quarter-on-quarter, and expectations for a further narrowing of revenue decline and an increase in profit margins for the full year [1]
整治保健品虚假宣传 市场监管总局公布6起典型案例
Xin Hua Wang· 2025-08-12 06:24
Core Viewpoint - The State Administration for Market Regulation has launched a campaign against false advertising in health products, particularly targeting misleading claims made to elderly consumers [1][2][3] Group 1: Regulatory Actions - The campaign has revealed six typical cases of false advertising in health products, emphasizing the need for consumer awareness regarding the distinction between health foods and medicines [1] - In Nanjing, a food business was found promoting ordinary food products as having medicinal benefits, which were unsubstantiated [1] - A supermarket in Zhangjiagang was penalized for advertising a health product as a treatment for various diseases, despite it being a regular health food [1] Group 2: Marketing Tactics - A food store in Shanghai used free vegetable giveaways to attract elderly customers, subsequently promoting health products with false disease treatment claims [2] - A health management company in Ningbo employed gift giveaways to lure elderly individuals into marketing events, where exaggerated product claims were made [2] - A company in Beijing was found to be using live streaming to promote a regular food item as a weight loss solution, with no scientific backing for such claims [2][3] Group 3: Misleading Claims - A technology company in Beijing falsely claimed that its products could treat various health conditions, using unverified extreme terms to enhance product appeal [3] - The marketing practices across these cases highlight a systemic issue of misleading health claims in the industry, particularly targeting vulnerable populations like the elderly [1][2][3]
市场监管总局专项整治保健品市场“坑老”“骗老”行为
Xin Hua Wang· 2025-08-12 05:54
Core Viewpoint - The State Administration for Market Regulation has initiated a nationwide special campaign to combat false advertising in the pharmaceutical and health product sectors targeting the elderly, aiming to protect their rights and improve market competition [1] Regulatory Actions - The campaign will utilize various laws, including the Anti-Unfair Competition Law, Price Law, Advertising Law, Food Safety Law, Product Quality Law, and Consumer Rights Protection Law, to address issues such as false advertising, price fraud, illegal advertising, and illegal additives that harm the elderly [1] - Local market regulation departments will focus on collecting evidence of illegal activities through public participation, encouraging citizens to report suspected violations [1] Enforcement and Public Awareness - The regulatory bodies will analyze and address reported issues promptly, targeting significant cases that disrupt market order and publicizing these cases to create a deterrent effect [1] - The initiative aims to enhance collaboration among departments and promote public awareness to foster a societal consensus against false advertising, thereby safeguarding the health and safety of the elderly [1]
【汤臣倍健(300146.SZ)】收入继续承压,控费带动Q2利润同比改善——2025年半年度业绩点评(陈彦彤/汪航宇/聂博雅)
光大证券研究· 2025-08-11 23:05
Core Viewpoint - The company reported a decline in revenue and net profit for the first half of 2025, but showed signs of recovery in the second quarter, indicating potential for improvement in the latter half of the year [3][4]. Financial Performance - In 25H1, the company achieved revenue of 3.53 billion yuan, a year-on-year decrease of 23.4%, and a net profit of 740 million yuan, down 17.3%. In 25Q2, revenue was 1.74 billion yuan, a decline of 11.5%, while net profit increased by 71.4% to 280 million yuan [3]. - The gross profit margin for 25H1 was 68.55%, slightly down from the previous year, while the net profit margin improved significantly due to better cost control [5]. Brand and Channel Performance - The main brand "汤臣倍健" saw a revenue drop of 28.32% to 1.888 billion yuan in 25H1. The joint care brand "健力多" experienced a 30.35% decline, while "Life-Space" had mixed results with domestic revenue down 34.43% but overseas revenue up 13.46% [4]. - Sales through offline channels fell by 31.63% to 1.798 billion yuan, while online sales decreased by 13.78% to 1.684 billion yuan, reflecting a challenging market environment [4]. Cost Management and Profitability - The company managed to reduce its sales expense ratio to 34.9% in 25H1, down 4.59 percentage points year-on-year, contributing to improved net profit margins [5]. - The management expense ratio increased slightly due to revenue decline, but overall profitability metrics showed improvement in the second quarter [5]. Future Outlook - The company anticipates a single-digit decline in revenue for the full year 2025, with expectations of narrowing the decline compared to the first half [6]. - Initiatives for performance recovery include product innovation and a comprehensive channel reform strategy aimed at enhancing sales and customer engagement [6].
【光大研究每日速递】20250812
光大证券研究· 2025-08-11 23:05
Group 1: Engineering Machinery Industry - In July 2025, excavator sales in China (including exports) reached 17,138 units, a year-on-year increase of 25.2%, with domestic sales at 7,306 units, up 17.2% [5] - From January to July 2025, total excavator sales (including exports) amounted to 137,658 units, reflecting a year-on-year growth of 17.8%, while domestic sales were 72,943 units, increasing by 22.3% [5] Group 2: Fast Food Industry - Laoxiangji, a fast-food company, has a fully integrated supply chain with three chicken farms, two central kitchens, and eight distribution centers as of June 30, 2025 [5] - The company aims to become a "family kitchen" for customers, with an average customer spending of around 30 yuan, and is the only Chinese fast-food enterprise implementing a comprehensive traceability system [5] Group 3: Technology and Materials - Changqing Technology focuses on the R&D, production, and sales of special monomers and additives for high polymer new materials, with steady revenue and cash flow growth from 2019 to 2024 [6] - In 2024, the company achieved operating revenue of 1.08 billion yuan, a year-on-year increase of 6.0%, and a net profit attributable to shareholders of 204 million yuan, down 3.9% [7] Group 4: Property Management - New Dazheng has invested in nearly 100 environmental cleaning robots and inspection drones in various scenarios, exploring the synergy between "scenes and technology" [7] - The company's core business revenue for 2024 is projected to be 2.98 billion yuan, reflecting a year-on-year growth of 8.2%, accounting for 87.8% of total revenue [7] Group 5: Semiconductor Industry - SMIC reported Q2 2025 revenue of 2.209 billion USD, a year-on-year increase of 16.2%, although it experienced a quarter-on-quarter decline of 1.7% [8] - The company’s performance exceeded previous guidance and market expectations, with a decline attributed to changes in capacity mix affecting average selling prices [8] Group 6: Health Supplements - Tongchen Beijian's revenue for H1 2025 was 3.53 billion yuan, a year-on-year decrease of 23.4%, with a net profit of 740 million yuan, down 17.3% [8] - The company is facing pressure from weak demand and inventory adjustments, but cost control measures have led to significant improvements in net profit margins [8]